Justin B Schaal

Title: Innovations in Fungal Infection Treatment by Justin B Schaal

Introduction

Justin B Schaal is an accomplished inventor based in Orange, CA (US). He has made significant contributions to the field of medical science, particularly in the treatment of fungal infections. With a total of 4 patents to his name, Schaal's work focuses on novel therapeutic approaches that enhance immune response.

Latest Patents

Schaal's latest patents include compositions and methods for the treatment of fungal infections. He has developed novel peptide analogs of a θ-defensin that provide a biphasic effect in treating disseminated fungal disease and/or associated septic shock. These analogs are effective at concentrations below those needed for a fungicidal effect. They initially mobilize effector cells of the immune system to combat the infective organism, followed by the regulation of the immune system to downregulate the inflammatory response. Notably, these θ-defensin analogs are protective at concentrations where naturally occurring θ-defensins show no apparent effect. They include a core set of structural and sequence features not found in native θ-defensins.

Career Highlights

Schaal is affiliated with the University of Southern California, where he continues to advance his research and innovations. His work has garnered attention for its potential to revolutionize treatment protocols for fungal infections, which can be particularly challenging to manage.

Collaborations

Some of Schaal's notable coworkers include Michael E Selsted and Dat Q Tran. Their collaborative efforts contribute to the ongoing research and development of effective treatments in the field.

Conclusion

Justin B Schaal's innovative work in developing peptide analogs for treating fungal infections showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies that could significantly improve patient outcomes.